TrialCell reports. Medicine2025

UCPVax, a CD4 helper peptide vaccine, induces polyfunctional Th1 cells, antibody response, and epitope spreading to improve antitumor immunity.

Caroline Laheurte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.